BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24533278)

  • 1. Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia.
    Leitsch D; Schlosser S; Burgess A; Duchêne M
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():166-70. PubMed ID: 24533278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
    Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
    Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
    Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia.
    Leitsch D; Burgess AG; Dunn LA; Krauer KG; Tan K; Duchêne M; Upcroft P; Eckmann L; Upcroft JA
    J Antimicrob Chemother; 2011 Aug; 66(8):1756-65. PubMed ID: 21602576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
    Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
    Leitsch D
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
    Leitsch D; Kolarich D; Wilson IB; Altmann F; Duchêne M
    PLoS Biol; 2007 Aug; 5(8):e211. PubMed ID: 17676992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study.
    Bassily S; Farid Z; el-Masry NA; Mikhail EM
    J Trop Med Hyg; 1987 Feb; 90(1):9-12. PubMed ID: 3546716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
    Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
    J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Adagu IS; Nolder D; Warhurst DC; Rossignol JF
    J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted intracellular redox balance of the diplomonad fish parasite Spironucleus vortens by 5-nitroimidazoles and garlic-derived compounds.
    Williams CF; Lloyd D; Kolarich D; Alagesan K; Duchêne M; Cable J; Williams D; Leitsch D
    Vet Parasitol; 2012 Nov; 190(1-2):62-73. PubMed ID: 22677132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis.
    Kaneda Y; Torii M; Tanaka T; Aikawa M
    Ann Trop Med Parasitol; 1991 Aug; 85(4):417-25. PubMed ID: 1796883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
    Leitsch D; Kolarich D; Duchêne M
    Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases).
    Pal D; Banerjee S; Cui J; Schwartz A; Ghosh SK; Samuelson J
    Antimicrob Agents Chemother; 2009 Feb; 53(2):458-64. PubMed ID: 19015349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target.
    Leitsch D; Müller J; Müller N
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):148-153. PubMed ID: 27485086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Potent 1
    Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
    Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.